Psychologic intervention improves survival for breast cancer patients

The question of whether stress poses a risk for cancer progression has been difficult to answer. A randomized clinical trial tested the hypothesis that cancer patients coping with their recent diagnosis but receiving a psychologic intervention would have improved survival compared with patients who were only assessed.

[1]  J. Wardle,et al.  Do stress-related psychosocial factors contribute to cancer incidence and survival? , 2008, Nature Clinical Practice Oncology.

[2]  B. Andersen,et al.  Immune, endocrine, and behavioral precursors to breast cancer recurrence: a case-control analysis , 2008, Cancer Immunology, Immunotherapy.

[3]  Liz Y. Han,et al.  Effect of interleukin-8 gene silencing with liposome-encapsulated small interfering RNA on ovarian cancer cell growth. , 2008, Journal of the National Cancer Institute.

[4]  S. Ancoli-Israel,et al.  Neuroendocrine-immune mechanisms of behavioral comorbidities in patients with cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  Yuelin Li,et al.  Effects of supportive‐expressive group therapy on survival of patients with metastatic breast cancer: A randomized prospective trial , 2008, Cancer.

[6]  D. Golden-Kreutz,et al.  RCT of a psychological intervention for patients with cancer: I. mechanisms of change. , 2007, Journal of consulting and clinical psychology.

[7]  F. Dhabhar,et al.  CHAPTER 34 – Bi-directional Effects of Stress on Immune Function: Possible Explanations for Salubrious as Well as Harmful Effects , 2007 .

[8]  J. Leips,et al.  Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression. , 2007, Cancer research.

[9]  Timothy R. Crespin,et al.  Distress reduction from a psychological intervention contributes to improved health for cancer patients , 2007, Brain, Behavior, and Immunity.

[10]  Cheryl Koopman,et al.  Effects of supportive‐expressive group therapy on survival of patients with metastatic breast cancer , 2007, Cancer.

[11]  Sidney Bloch,et al.  Supportive‐expressive group therapy for women with metastatic breast cancer: survival and psychosocial outcome from a randomized controlled trial , 2007, Psycho-oncology.

[12]  A. Sood,et al.  The Neuroendocrine Impact of Chronic Stress on Cancer , 2007, Cell cycle.

[13]  Liz Y. Han,et al.  Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma , 2006, Nature Medicine.

[14]  P. McDonald,et al.  The influence of bio-behavioural factors on tumour biology: pathways and mechanisms , 2006, Nature Reviews Cancer.

[15]  Liz Y. Han,et al.  Stress Hormone–Mediated Invasion of Ovarian Cancer Cells , 2006, Clinical Cancer Research.

[16]  Stefano Iacobelli,et al.  Elevated Serum Cytokines Correlated with Altered Behavior, Serum Cortisol Rhythm, and Dampened 24-Hour Rest-Activity Patterns in Patients with Metastatic Colorectal Cancer , 2005, Clinical Cancer Research.

[17]  Timothy R. Crespin,et al.  Psychological, behavioral, and immune changes after a psychological intervention: a clinical trial. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  S. Devesa,et al.  Probabilities of death from breast cancer and other causes among female breast cancer patients. , 2004, Journal of the National Cancer Institute.

[19]  Wei Wu,et al.  Microarray Analysis Reveals Glucocorticoid-Regulated Survival Genes That Are Associated With Inhibition of Apoptosis in Breast Epithelial Cells , 2004, Cancer Research.

[20]  S. Bloch,et al.  Cognitive‐existential group psychotherapy for women with primary breast cancer: A randomised controlled trial , 2003, Psycho-oncology.

[21]  Andrew H. Miller,et al.  Depression in cancer: new developments regarding diagnosis and treatment , 2003, Biological Psychiatry.

[22]  M. Stockler,et al.  Consensus on Medical Treatment of Metastatic Breast Cancer , 2003, Breast Cancer Research and Treatment.

[23]  J. Bos,et al.  Cyclic AMP induces integrin-mediated cell adhesion through Epac and Rap1 upon stimulation of the β2-adrenergic receptor , 2003, The Journal of cell biology.

[24]  Marion K Campbell,et al.  The method of minimization for allocation to clinical trials. a review. , 2002, Controlled clinical trials.

[25]  H. Anisman,et al.  Cytokines as a stressor: implications for depressive illness. , 2002, The international journal of neuropsychopharmacology.

[26]  P. Andrews,et al.  Fatigue associated with cancer and its treatment , 2002, Supportive Care in Cancer.

[27]  G. Chrousos,et al.  Stress Hormones, Proinflammatory and Antiinflammatory Cytokines, and Autoimmunity , 2002, Annals of the New York Academy of Sciences.

[28]  H. Chochinov,et al.  The effect of group psychosocial support on survival in metastatic breast cancer. , 2001, The New England journal of medicine.

[29]  P. Rutkowski,et al.  Alterations of routine blood tests in adult patients with soft tissue sarcomas: relationships to cytokine serum levels and prognostic significance. , 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

[30]  K. Zänker,et al.  Norepinephrine-induced migration of SW 480 colon carcinoma cells is inhibited by beta-blockers. , 2001, Cancer research.

[31]  J Lellouch,et al.  Marked 24-h rest/activity rhythms are associated with better quality of life, better response, and longer survival in patients with metastatic colorectal cancer and good performance status. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[32]  H. Kraemer,et al.  Diurnal cortisol rhythm as a predictor of breast cancer survival. , 2000, Journal of the National Cancer Institute.

[33]  V. Kalinichenko,et al.  Norepinephrine-Mediated Inhibition of Antitumor Cytotoxic T Lymphocyte Generation Involves a β-Adrenergic Receptor Mechanism and Decreased TNF-α Gene Expression , 1999, The Journal of Immunology.

[34]  P. Maguire,et al.  The effect of psychological interventions on anxiety and depression in cancer patients: results of two meta-analyses , 1999, British Journal of Cancer.

[35]  R. MacCallum,et al.  Stress and immune responses after surgical treatment for regional breast cancer. , 1998, Journal of the National Cancer Institute.

[36]  Z. Kronfol,et al.  Circadian Immune Measures in Healthy Volunteers: Relationship to Hypothalamic-Pituitary-Adrenal Axis Hormones and Sympathetic Neurotransmitters , 1997, Psychosomatic medicine.

[37]  V. Stefanski,et al.  Social confrontation and tumor metastasis in rats: Defeat and β-adrenergic mechanisms , 1996, Physiology & Behavior.

[38]  A. Novelli,et al.  EVIDENCE FOR FUNCTIONAL β-ADRENOCEPTOR SUBTYPES IN CG-5 BREAST CANCER CELLS , 1996 .

[39]  B. Andersen,et al.  A biobehavioral model of cancer stress and disease course. , 1994, The American psychologist.

[40]  L. Berkman,et al.  Two Shorter Forms of the CES-D Depression Symptoms Index , 1993 .

[41]  R. Yirmiya,et al.  Stress increases metastatic spread of a mammary tumor in rats: Evidence for mediation by the immune system , 1991, Brain, Behavior, and Immunity.

[42]  M. Horowitz,et al.  Impact of Event Scale: A Measure of Subjective Stress , 1979, Psychosomatic medicine.

[43]  L. Freedman,et al.  Allocation of patients to treatment groups in a controlled clinical study. , 1978, British Journal of Cancer.

[44]  Sigrid Bekmeier-Feuerhahn,et al.  Mechanisms of Change , 2009 .

[45]  A. Lamazza,et al.  A Randomized Prospective Trial , 2009 .

[46]  N. Adler,et al.  Cancer care for the whole patient : meeting psychosocial health needs , 2008 .

[47]  John T. Woosley,et al.  Circulating levels of inflammatory cytokines and risk of colorectal adenomas. , 2008, Cancer research.

[48]  J. Holland,et al.  The Effectiveness of Psychosocial Interventions for Women with Breast Cancer , 2004 .

[49]  J. Holland,et al.  Meeting Psychosocial Needs of Women with Breast Cancer , 2004 .

[50]  C. Compton,et al.  AJCC Cancer Staging Manual , 2002, Springer New York.

[51]  V. Kalinichenko,et al.  Norepinephrine-mediated inhibition of antitumor cytotoxic T lymphocyte generation involves a beta-adrenergic receptor mechanism and decreased TNF-alpha gene expression. , 1999, Journal of immunology.

[52]  W. Redd.  Behavioral intervention for cancer treatment side effects. , 1994, Acta oncologica.

[53]  F. Révillion,et al.  Functional beta-adrenergic receptors in breast cancer cells. , 1990, Journal of cancer research and clinical oncology.

[54]  M. Lorr,et al.  Manual for the Profile of Mood States , 1971 .

[55]  D. Karnofsky.  The clinical evaluation of chemotherapeutic agents in cancer , 1949 .

[56]  Colin M. MacLeod,et al.  Evaluation of chemotherapeutic agents , 1949 .

[57]  D.,et al.  Regression Models and Life-Tables , 2022 .